Category: Eliem
-
Eliem therapeutics executive sells over $9,000 in company stock By Investing.com
•
According to a new filing with the U.S. Securities and Exchange Commission, Emily Pimblett, chief accounting officer of Eliem Therapeutics, Inc. (NASDAQ:ELYM), recently sold a portion of her company’s stock. The transactions, which took place on September 20, 2024, involved the sale of 1,182 shares at $8.18 each and 9…
-
Eliem therapeutics executive sells over $9,000 in company stock By Investing.com
•
According to a new filing with the U.S. Securities and Exchange Commission, Emily Pimblett, chief accounting officer of Eliem Therapeutics, Inc. (NASDAQ:ELYM), recently sold a portion of her company’s stock. The transactions, which took place on September 20, 2024, involved the sale of 1,182 shares at $8.18 each and 9…
-
Eliem Therapeutics EVP sells $338,000 in stock By Investing.com
•
Valerie Morissette, Executive Vice President of Research and Development and Chief Scientific Officer of Eliem Therapeutics, Inc. (NASDAQ:ELYM), sold a significant number of shares of the company. On July 3, 2024, Morissette disposed of 50,000 shares of common stock at an average price of $6.76, resulting in a total net…